Founded 21 years ago by immunologist Rabinder Buttar, 54, this Glasgow company provides clinical research services to the pharmaceutical, biotechnology and medical device industries. It specialises in clinical trials for cancer and rare disease therapies and has a presence in more than 50 countries worldwide. International sales account for more than 99% of total revenue, and reached £51.7m in 2017.
This profile reflects the company at time of publication and does not reflect any changes that may have subsequently occurred. Fast Track and its sponsors do not endorse, guarantee or recommend investment in any of the companies.